Drug:
Reaction: ERYTHEMA
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25067508 |
US |
76 | 2 |
Dizziness, Vertigo, Night sweats, Nausea, Fatigue, Pain in extremity, Erythema, Off label use, |
||||
TREPROSTINIL, TREPROSTINIL, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, FAMOTIDINE, FUROSEMIDE, ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LEFLUNOMIDE, ACETAMINOPHEN, LEVOTHYROXINE, MAGNESIUM OXIDE, TOCILIZUMAB, ACETAMINOPHEN, DIPHENHYDRAMINE HYDROCHLORIDE, ACETAMINOPHEN AND DIPHENHYDRAMINE HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, HYDROXYCHLOROQUINE SULFATE, ERGOCALCIFEROL, FLUTICASONE PROPIONATE, MACITENTAN, OXYGEN, 0XYGEN, GABAPENTIN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, ONDANSETRON HYDROCHLORIDE, |
||||
| 502 | 25067601 |
CN |
89 | 2 |
Tenderness, Chills, Erythema, Contrast media allergy, |
||||
IOHEXOL, |
||||
| 503 | 25067747 |
GB |
25 | 2 |
Eye swelling, Erythema, Injection site pain, Injection site swelling, Injection site reaction, |
||||
BOTULINUM TOXIN TYPE A, |
||||
| 504 | 25067773 |
ES |
76 | 2 |
Intestinal prolapse, Abnormal faeces, Chromaturia, Constipation, Cyst, Diarrhoea, Erythema, Faeces discoloured, Faeces hard, Hyperhidrosis, Haemorrhoids, Haemorrhoidal haemorrhage, Hot flush, Hepatic cyst, Limb discomfort, Nervousness, Pruritus, Peripheral swelling, Pain in extremity, Weight increased, Somnolence, Sleep disorder, Stress, Tooth fracture, Varicose vein, Anal fissure, Blood urine present, Urinary tract infection, |
||||
LETROZOLE, LETROZOLE TABLETS, ABEMACICLIB, ABEMACICLIB, ABEMACICLIB, APIXABAN, |
||||
| 505 | 25067863 |
CA |
58 | 2 |
Abdominal pain, Abdominal pain lower, Blood pressure abnormal, Body temperature decreased, Bone pain, Breast cancer, Drug hypersensitivity, Ear swelling, Erythema, Headache, Illness, Joint stiffness, Oropharyngeal pain, Papule, Paraesthesia, Pruritus, Quality of life decreased, Rubber sensitivity, Sensitive skin, Skin exfoliation, Skin lesion, Skin plaque, Stress, Urticaria, Wound, Inappropriate schedule of product administration, Incorrect dose administered, Product availability issue, Product container issue, Product dose omission issue, Therapeutic response decreased, Therapy partial responder, |
||||
NAPROXEN, NAPROXEN SODIUM, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, HYDROXYZINE, |
||||
| 506 | 25067960 |
IT |
86 | 2 |
Rash maculo-papular, Erythema, Decreased appetite, Nausea, |
||||
ALLOPURINOL, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, OLMESARTAN MEDOXOMIL, LINAGLIPTIN, |
||||
| 507 | 25068078 |
PL |
49 | 2 |
Hypersensitivity, Localised oedema, Abdominal pain, Erythema, Cough, |
||||
CARBOPLATIN, |
||||
| 508 | 25068090 |
FR |
66 | 1 |
Erythema, Rash, Anaemia, C-reactive protein increased, Off label use, |
||||
TRAMETINIB, |
||||
| 509 | 25068114 |
JP |
2 | |
Anaphylactic reaction, Nausea, Pruritus, Erythema, |
||||
SELEXIPAG, IOPAMIDOL, IOMEPROL INJECTION, VONOPRAZAN FUMARATE, RIOCIGUAT, IOHEXOL, |
||||
| 510 | 25068233 |
CN |
14 | 2 |
Pancreatitis acute, Mouth ulceration, Myelosuppression, Abdominal pain, Nausea, Amylase increased, Lipase increased, Pharyngeal erythema, Erythema, Swelling, Mucosal erosion, Gingival pain, |
||||
CYTARABINE, CYTARABINE, METHOTREXATE SODIUM, DEXAMETHASONE SODIUM PHOSPHATE, DEXAMETHASONE SODIUM PHOSPHATE, PEGASPARGASE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, NORMAL SALT TABLETS, |
||||
| 511 | 25068325 |
US |
43 | 2 |
Dermatitis atopic, Erythema, Skin fissures, Surgery, |
||||
DUPILUMAB, |
||||
| 512 | 25068420 |
US |
19 | 1 |
Erythema, |
||||
DUPILUMAB, |
||||
| 513 | 25068435 |
US |
10 | 1 |
Skin swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 514 | 25068457 |
US |
66 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 515 | 25068580 |
US |
29 | 2 |
Dermatitis atopic, Rash pruritic, Skin irritation, Skin haemorrhage, Erythema, Swelling face, Dry skin, |
||||
DUPILUMAB, ERGOCALCIFEROL, |
||||
| 516 | 25068598 |
US |
35 | 2 |
Erythema, Rash macular, Rash, Therapeutic response decreased, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 517 | 25068681 |
US |
3 | 2 |
Flushing, Erythema, Ocular hyperaemia, |
||||
DUPILUMAB, |
||||
| 518 | 25068891 |
US |
19 | 1 |
Somnolence, Peripheral swelling, Erythema, Pruritus, |
||||
DUPILUMAB, DUPILUMAB, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 519 | 25068898 |
US |
41 | 1 |
Dermatitis atopic, Dermatitis, Skin burning sensation, Erythema, Dry skin, Skin exfoliation, |
||||
DUPILUMAB, |
||||
| 520 | 25069005 |
US |
1 | |
Pruritus, Erythema, Skin fissures, Therapeutic response shortened, |
||||
DUPILUMAB, |
||||
| 521 | 25069170 |
US |
67 | 2 |
Swelling, Erythema, |
||||
DUPILUMAB, |
||||
| 522 | 25069357 |
83 | 2 | |
Extravasation, Oedema, Pain, Erythema, Skin exfoliation, Pneumonia aspiration, Dysphagia, Hypernatraemia, |
||||
PEMBROLIZUMAB, APIXABAN, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, EMPAGLIFLOZIN, LETROZOLE, LETROZOLE TABLETS, LEVOTHYROXINE, ROSUVASTATIN, TORSEMIDE, |
||||
| 523 | 25069387 |
US |
82 | 2 |
Urticaria, Erythema, Pruritus, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, |
||||
| 524 | 25069716 |
CA |
69 | 1 |
Anxiety, COVID-19, Cough, Erythema, Nasopharyngitis, Productive cough, Rhinorrhoea, Tooth infection, Urticaria, Inappropriate schedule of product administration, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, AMLODIPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CIPROFLOXACIN HYDROCHLORIDE AND HYDROCORTISONE, CIPROFLOXACIN HYDROCHLORIDE, CIPROFLOXACIN, METRONIDAZOLE, MONTELUKAST, PREDNISONE, RANITIDINE, |
||||
| 525 | 25070060 |
US |
19 | 1 |
Oedema, Erythema, |
||||
OLANZAPINE, CLONAZEPAM, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, DIVALPROEX SODIUM, LORAZEPAM, PALIPERIDONE, ZIPRASIDONE, |
||||
| 526 | 25070236 |
US |
54 | 2 |
Throat irritation, Erythema, Nausea, Headache, |
||||
BREMELANOTIDE, |
||||
| 527 | 25070272 |
AR |
46 | 2 |
Gastrointestinal disorder, Skin disorder, Inflammation, Diarrhoea, Headache, Application site inflammation, Pruritus, Erythema, Dermatitis atopic, Glossitis, Gastrointestinal pain, Musculoskeletal pain, Oral mucosal blistering, Perioral dermatitis, Hypersensitivity, |
||||
| 528 | 25070350 |
FR |
49 | 1 |
Erythema, Off label use, |
||||
CYTARABINE, CYTARABINE, CYTARABINE, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PHYTONADIONE, VALACYCLOVIR HYDROCHLORIDE, VALACYCLOVIR, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, PANTOPRAZOLE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, |
||||
| 529 | 25070444 |
US |
19 | 2 |
Dermatitis atopic, Erythema, Condition aggravated, Inflammation, Injection site pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 530 | 25070587 |
US |
47 | 1 |
Erythema, Injection site pain, Eczema, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, HALOBETASOL PROPIONATE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, GUAIFENESIN, FEXOFENADINE HYDROCHLORIDE, FEXOFENADINE HYDROCHLORIDE ORAL, FEXOFENADINE HCL, MONTELUKAST SODIUM, IPRATROPIUM BROMIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, ATORVASTATIN CALCIUM, CALCIPOTRIENE, TAFLUPROST, FISH OIL, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 531 | 25070590 |
US |
25 | 1 |
Skin fissures, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 532 | 25070662 |
US |
47 | 2 |
Erythema, |
||||
DUPILUMAB, |
||||
| 533 | 25070678 |
ES |
15 | 1 |
Lip oedema, Erythema, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 534 | 25070746 |
US |
2 | |
Eczema, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 535 | 25070747 |
US |
||
Chest pain, Hypotension, Hypertension, Bradycardia, Electrocardiogram QT prolonged, Electrocardiogram abnormal, Tachycardia, Conduction disorder, Depressed level of consciousness, Rhabdomyolysis, Syncope, Intentional product misuse, Electrolyte imbalance, Blood creatinine increased, Dizziness, Vertigo, Visual impairment, Somnolence, Lethargy, Agitation, Dysarthria, Tremor, Headache, Tinnitus, Muscular weakness, Neurological symptom, Vomiting, Nausea, Diarrhoea, Dyspnoea, Cyanosis, Erythema, Flushing, Hyperhidrosis, Drug ineffective, Adverse drug reaction, Therapeutic product effect incomplete, Accidental exposure to product, Accidental exposure to product by child, Medication error, |
||||
IVABRADINE, |
||||
| 536 | 25070759 |
US |
1 | |
Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 537 | 25070768 |
US |
54 | 2 |
Neurodermatitis, Skin exfoliation, Erythema, Pruritus, |
||||
DUPILUMAB, |
||||
| 538 | 25070807 |
US |
78 | 2 |
Skin burning sensation, Erythema, Off label use, |
||||
DUPILUMAB, BENRALIZUMAB, |
||||
| 539 | 25070883 |
US |
2 | |
Migraine, Skin swelling, Erythema, Hypersensitivity, |
||||
DUPILUMAB, DUPILUMAB, PAROXETINE HYDROCHLORIDE, BENRALIZUMAB, RIZATRIPTAN BENZOATE, MONTELUKAST SODIUM, FLUTICASONE PROPIONATE, TIOTROPIUM BROMIDE INHALATION SPRAY, MOMETASONE FUROATE AND FORMOTEROL FUMARATE DIHYDRATE, ALBUTEROL SULFATE, |
||||
| 540 | 25071254 |
CN |
67 | 2 |
Periorbital oedema, Pruritus, Pyrexia, Rash, Face oedema, Erythema, |
||||
| 541 | 25071255 |
US |
45 | 2 |
N-terminal prohormone brain natriuretic peptide increased, Weight decreased, Erythema, Dyspnoea, Rash, Chest pain, Troponin increased, Incorrect dose administered, |
||||
SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SOTATERCEPT-CSRK, SEMAGLUTIDE, |
||||
| 542 | 25061277 |
US |
64 | 2 |
Eye pruritus, Throat irritation, Pruritus, Erythema, |
||||
TIOTROPIUM BROMIDE INHALATION SPRAY, |
||||
| 543 | 25061718 |
ES |
58 | 1 |
Erythema, Face oedema, Pruritus, Urticaria, Malaise, |
||||
ROSUVASTATIN, |
||||
| 544 | 25061724 |
US |
2 | |
Erythema, Pruritus, |
||||
INCLISIRAN, |
||||
| 545 | 25061771 |
IT |
43 | 2 |
Malaise, Pruritus, Erythema, |
||||
AMOXICILLIN, |
||||
| 546 | 25061845 |
CA |
57 | 2 |
Abdominal pain, Abdominal pain upper, Alopecia, Amnesia, Bacterial test positive, Constipation, Crohn^s disease, Cytomegalovirus infection, Dizziness, Drug ineffective, Erythema, Eye swelling, Fatigue, Frequent bowel movements, Headache, Limb injury, Ocular hyperaemia, Off label use, Onychomadesis, Pruritus, Psoriasis, Pyrexia, Rash macular, Skin fissures, Stress, |
||||
USTEKINUMAB, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, VEDOLIZUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, |
||||
| 547 | 25062272 |
GB |
||
Joint swelling, Erythema, |
||||
ADALIMUMAB, ADALIMUMAB, AMLODIPINE, MESALAMINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, |
||||
| 548 | 25062474 |
HU |
2 | |
Breast cancer, Malignant neoplasm progression, Metastases to bone, Metastases to ovary, Renal impairment, Metastases to uterus, Vertebral lesion, Rash, Erythema, Skin exfoliation, Tumour marker increased, Bone lesion, |
||||
RIBOCICLIB, LETROZOLE, LETROZOLE TABLETS, FULVESTRANT, |
||||
| 549 | 25062616 |
CA |
69 | 2 |
Nephrolithiasis, Musculoskeletal stiffness, Neck pain, Pyrexia, Cataract, Contraindicated product administered, Discomfort, Fatigue, Joint swelling, Mouth ulceration, Pruritus, Erythema, Fall, Influenza, Ankle fracture, Arthralgia, Back pain, COVID-19, Urinary tract infection, Phlebitis, |
||||
DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, SECUKINUMAB, CELECOXIB, CELECOXIB, HYDROMORPHONE HYDROCHLORIDE, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, GOLIMUMAB, GOLIMUMAB, |
||||
| 550 | 25062722 |
ES |
15 | 1 |
Erythema, Lip oedema, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, |
||||
| 551 | 25062861 |
US |
1 | |
Erythema, |
||||
CABOTEGRAVIR, CABOTEGRAVIR, CABOTEGRAVIR, |
||||
| 552 | 25062926 |
US |
55 | 2 |
Pruritus, Erythema, White blood cell count decreased, Skin disorder, Off label use, |
||||
BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, BRENTUXIMAB VEDOTIN, MECHLORETHAMINE HYDROCHLORIDE, |
||||
| 553 | 25063202 |
CA |
50 | 2 |
Angioedema, Drug ineffective, Erythema, Lip swelling, Residual symptom, Swelling, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, |
||||
| 554 | 25063286 |
59 | 1 | |
Nausea, Vomiting, Abdominal pain, Hypophagia, Dizziness postural, Colitis, Proctitis, Hyponatraemia, Hypokalaemia, Neutropenia, Toxicity to various agents, Diarrhoea, Palmar-plantar erythrodysaesthesia syndrome, Mucosal inflammation, Gastrooesophageal reflux disease, Decreased appetite, Asthenia, Erythema, Sensitive skin, Stomatitis, Cheilitis, |
||||
CAPECITABINE, |
||||
| 555 | 25063330 |
IT |
54 | 2 |
Kounis syndrome, Loss of consciousness, Cardiac arrest, Cyanosis, Erythema, Dyspnoea, |
||||
| 556 | 25063379 |
CA |
51 | 2 |
Discomfort, Erythema, Eye pain, Fatigue, Paraesthesia, Rash, Skin burning sensation, Skin swelling, Urticaria, Vision blurred, |
||||
OFATUMUMAB, IRON, MAGNESIUM, PROGESTERONE, VITAMIN C, ERGOCALCIFEROL, |
||||
| 557 | 25063468 |
CA |
40 | 2 |
Angioedema, Asthma, Chest discomfort, COVID-19, Ear pain, Herpes zoster oticus, Ear swelling, Erythema, Hypersensitivity, Urticaria, Swelling, Product dose omission issue, Drug ineffective, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, |
||||
| 558 | 25063568 |
LU |
68 | 2 |
Hyperhidrosis, Pruritus, Vision blurred, Feeling hot, Erythema, Infusion related reaction, Off label use, |
||||
OXALIPLATIN, OXALIPLATIN, APREPITANT, FOSAPREPITANT DIMEGLUMINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ATROPINE SULFATE, ATROPINE, |
||||
| 559 | 25063807 |
US |
2 | |
Erythema, Dry eye, Fatigue, |
||||
| 560 | 25064237 |
ES |
62 | 2 |
Infusion related reaction, Erythema, Dizziness, |
||||
PACLITAXEL, |
||||
| 561 | 25064304 |
CA |
43 | 2 |
Angioedema, Blood oestrogen decreased, Ear swelling, Erythema, Illness, Inappropriate schedule of product administration, Lichen planus, Lip swelling, Nasopharyngitis, Peripheral swelling, Product availability issue, Pruritus, Rash, Skin abrasion, Urticaria, Weight decreased, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, DIPHENHYDRAMINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, LORATADINE, LORATADINE TABLET, MEDROXYPROGESTERONE ACETATE, PREDNISONE, PREDNISONE, |
||||
| 562 | 25064562 |
CN |
38 | 2 |
Anaphylactic shock, Urinary incontinence, Dizziness, Headache, Erythema, Loss of consciousness, Blood pressure immeasurable, Hypoaesthesia, |
||||
IOPROMIDE, IOPROMIDE, |
||||
| 563 | 25064581 |
US |
38 | 2 |
Swelling, Erythema, Discomfort, Norovirus infection, Vomiting, Headache, |
||||
OCRELIZUMAB AND HYALURONIDASE, |
||||
| 564 | 25064620 |
CA |
38 | 2 |
Arthralgia, Blood pressure increased, Breast pain, Bronchitis, Cough, Drug hypersensitivity, Dyspnoea, Eczema, Erythema, Fall, Fluid retention, Hypersensitivity, Menstrual disorder, Nasopharyngitis, Oropharyngeal pain, Rash, Rotator cuff syndrome, Shoulder fracture, Skin discolouration, Sputum discoloured, Thermal burn, Type 2 diabetes mellitus, Urinary tract infection, Urticaria, Weight decreased, Weight increased, Product availability issue, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CLINDAMYCIN PHOSPHATE, CLINDAMYCIN, CEFPROZIL, LORATADINE, LORATADINE TABLET, MONTELUKAST, ALBUTEROL SULFATE, |
||||
| 565 | 25064790 |
US |
80 | 2 |
Nasal inflammation, Somnolence, Erythema, |
||||
| 566 | 25064803 |
CA |
43 | 2 |
COVID-19, Decreased immune responsiveness, Diverticulitis, Dyspepsia, Erythema, Eye pruritus, Eye swelling, Fatigue, Feeling abnormal, Hypersensitivity, Infected cyst, Intervertebral disc protrusion, Weight decreased, Pain, Pneumonia, Pruritus, Rash, Rhinorrhoea, Skin plaque, Sneezing, Urticaria chronic, Swelling, Nasopharyngitis, Oropharyngeal pain, Urticaria, Product storage error, Product dose omission issue, Inappropriate schedule of product administration, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, |
||||
| 567 | 25065125 |
IL |
2 | |
Erythema, Paraesthesia, Pruritus, |
||||
IRON SUCROSE, |
||||
| 568 | 25065397 |
US |
62 | 2 |
Erythema, Pruritus, |
||||
IOHEXOL, |
||||
| 569 | 25065744 |
GB |
79 | 1 |
Joint swelling, Erythema, |
||||
AMLODIPINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, MESALAMINE, |
||||
| 570 | 25067725 |
58 | 2 | |
Cyanosis, Erythema, Choking, Swelling, Tongue disorder, Ligament rupture, Drug ineffective, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, OFATUMUMAB, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, DALFAMPRIDINE, FOLIC ACID, VITAMIN C, |
||||
| 571 | 25068405 |
69 | 2 | |
Infusion related reaction, Feeling hot, Erythema, Dyspnoea, Palpitations, Blood pressure systolic increased, Therapy interrupted, Infusion site pain, Headache, Chills, |
||||
DONANEMAB-AZBT, |
||||
| 572 | 25056277 |
GB |
1 | |
Mental impairment, Gout, Pain, Swelling, Ill-defined disorder, Memory impairment, Inappropriate schedule of product administration, Depressed mood, Psoriasis, Dry skin, Groin pain, Erythema, Stress, |
||||
SECUKINUMAB, SECUKINUMAB, |
||||
| 573 | 25056417 |
JP |
50 | 2 |
Metastases to liver, Metastases to bone, Breast mass, Erythema, |
||||
DENOSUMAB, |
||||
| 574 | 25056432 |
FR |
47 | |
Face oedema, Erythema, Angioedema, |
||||
OLAPARIB, |
||||
| 575 | 25056520 |
US |
21 | 2 |
Exfoliative rash, Erythema, Rash, |
||||
DUPILUMAB, |
||||
| 576 | 25056533 |
US |
52 | 2 |
Dermatitis atopic, Pruritus, Erythema, |
||||
DUPILUMAB, |
||||
| 577 | 25056635 |
US |
75 | 1 |
Erythema, Rash, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 578 | 25056739 |
US |
44 | 1 |
Pruritus, Erythema, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 579 | 25056744 |
US |
33 | 1 |
Erythema, Vision blurred, |
||||
DUPILUMAB, |
||||
| 580 | 25056804 |
US |
63 | 2 |
Discomfort, Skin burning sensation, Erythema, Haemorrhage, Pain, Rash, |
||||
INSULIN LISPRO, INSULIN GLARGINE, |
||||
| 581 | 25056808 |
US |
||
Erythema, |
||||
LEBRIKIZUMAB-LBKZ, |
||||
| 582 | 25056945 |
ES |
||
Erythema, Erythema, Lip oedema, |
||||
AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, |
||||
| 583 | 25057105 |
US |
45 | 1 |
Drug hypersensitivity, Rash, Pruritus, Erythema, Fatigue, Chest pain, |
||||
TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, TENOFOVIR DISOPROXIL FUMARATE, TENOFOVIR DISOPROXIL FUMARATE TABLETS, |
||||
| 584 | 25057503 |
US |
||
Fungal infection, Peripheral swelling, Haemorrhoids, Eye infection, Pruritus, Contusion, Haemorrhoidal haemorrhage, Panic attack, Eye pruritus, Inflammation, Erythema, Fear, Therapy change, Therapy cessation, |
||||
DAPAGLIFLOZIN, |
||||
| 585 | 25057612 |
US |
15 | 2 |
Erythema, Injection site pain, |
||||
TRALOKINUMAB-LDRM, |
||||
| 586 | 25057841 |
CA |
72 | 2 |
Alopecia, Aphonia, Arthralgia, Back pain, Blood pressure systolic increased, Bronchitis, Burning sensation, COVID-19, Diarrhoea, Erythema, Fatigue, Feeling abnormal, Gait inability, Ill-defined disorder, Injection site pain, Influenza, Insomnia, Ligament sprain, Mental disorder, Musculoskeletal stiffness, Myalgia, Nausea, Osteoarthritis, Pain, Pain in extremity, Peripheral swelling, Product dose omission issue, Pruritus, Pustule, Pyrexia, Shock, Skin burning sensation, Skin plaque, Somnolence, Swelling, Therapy partial responder, Urticaria, Weight increased, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, LORAZEPAM, LORAZEPAM, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, SUCRALFATE, SUCRALFATE ORAL SUSPENSION, SUCRALFATE ORAL, TIMOLOL, TIMOLOL, |
||||
| 587 | 25058092 |
GB |
||
Swelling face, Facial pain, Erythema, Rash, |
||||
DIMETHYL FUMARATE, DIMETHYL-FUMARATE, DIMETHYL FUMARATE KIT, |
||||
| 588 | 25058243 |
IT |
52 | 2 |
Infusion related hypersensitivity reaction, Erythema, Dyspnoea, Infusion related hypersensitivity reaction, Rash, Oxygen saturation decreased, Extrasystoles, |
||||
CARBOPLATIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, |
||||
| 589 | 25058348 |
US |
73 | 2 |
Flushing, Erythema, |
||||
TAFAMIDIS, |
||||
| 590 | 25058741 |
GB |
36 | 2 |
Angioedema, Urticaria, Erythema, Maternal exposure during breast feeding, |
||||
ROCURONIUM, ROCURONIUM BROMIDE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, PROPOFOL, |
||||
| 591 | 25058800 |
CA |
72 | 2 |
Abdominal distension, Abdominal pain, Abdominal pain lower, Acne, Arthralgia, Back pain, Blood pressure systolic increased, Blood potassium decreased, Body temperature decreased, Bursitis, Constipation, Contusion, Diarrhoea, Dizziness, Drug hypersensitivity, Dyspnoea, Erythema, Fatigue, Gingival abscess, Headache, Heart rate decreased, Hot flush, Hypokinesia, Hypotension, Incorrect dose administered, Musculoskeletal pain, Nausea, Pneumonia, Product administration error, Productive cough, Renal impairment, Pruritus, Rhinorrhoea, Sciatic nerve injury, Sinusitis, Somnolence, |
||||
OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, OCTREOTIDE ACETATE, ESTRADIOL/NORETHINDRONE ACETATE, DULOXETINE HYDROCHLORIDE, DULOXETIN HYDROCHLORIDE, DULOXETINE, CANDESARTAN, CANDESARTAN, ATENOLOL, ATENOLOL, ATENOLOL, AMLODIPINE, AMOXICILLIN, NAPROXEN, NAPROXEN SODIUM, FLUTICASONE FUROATE, BUDESONIDE, ESTRADIOL, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DOCUSATE SODIUM, DOCUSATE SODIUM 100MG, VENLAFAXINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LANSOPRAZOLE, POLYETHYLENE GLYCOL (3350), POLYETHYLENE GLYCOL 3350, POLYETHYLENE GLYCOL 400, NAPROXEN, NAPROXEN SODIUM, ROSUVASTATIN, LEVOTHYROXINE SODIUM, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, VITAMIN E, CREAM, |
||||
| 592 | 25058936 |
ES |
89 | 1 |
Pruritus, Erythema, |
||||
LEVOFLOXACIN, LEVOFLOXACIN IN 5% DEXTROSE, |
||||
| 593 | 25059052 |
CA |
67 | 1 |
Rib fracture, Fracture pain, Fall, Erythema, Headache, Feeling abnormal, |
||||
ADALIMUMAB-AFZB, DIPHENHYDRAMINE HYDROCHLORIDE, |
||||
| 594 | 25059074 |
PT |
76 | 1 |
Neutropenia, Rectal haemorrhage, Haemorrhoidal haemorrhage, Acute kidney injury, Atrial fibrillation, Respiratory failure, Hyperglycaemia, Cardiac failure, Neuropathy peripheral, Decreased appetite, Weight decreased, Dry skin, Erythema, Skin exfoliation, |
||||
ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, ENFORTUMAB VEDOTIN, DULOXETINE HYDROCHLORIDE, DULOXETINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, APIXABAN, APIXABAN, BISOPROLOL FUMARATE, BISOPROLOL FUMARATE, ROSUVASTATIN, ROSUVASTATIN, |
||||
| 595 | 25059155 |
IT |
20 | 2 |
Dyspnoea, Erythema, Nausea, Face oedema, |
||||
INFLIXIMAB, MESALAMINE, |
||||
| 596 | 25059298 |
CA |
||
Erythema, Burning sensation, Eye irritation, |
||||
LATANOPROST, LATANOPROST, LATANOPROST, LATANOPROST, |
||||
| 597 | 25059310 |
US |
2 | |
Dyspnoea, Arthralgia, Throat tightness, Sinus disorder, Candida infection, Application site laceration, Nasal discomfort, Erythema, Chest pain, Night sweats, Illness, Dysphonia, Dermatitis contact, Headache, Application site pain, Drug ineffective, Product substitution issue, |
||||
ESTRADIOL, |
||||
| 598 | 25059323 |
JP |
||
Erythema, |
||||
| 599 | 25059644 |
CA |
36 | 2 |
Asthma, Back pain, Bursitis, Coeliac disease, Constipation, Drug hypersensitivity, Drug ineffective, Drug intolerance, Erythema, Fatigue, Fluid retention, Food allergy, Headache, Hepatic enzyme increased, Hyperhidrosis, Hypersensitivity, Hypertension, Immunodeficiency, Infection, Infusion related reaction, Joint swelling, Pain, Product use issue, Psoriasis, Pyrexia, Rash, Rash erythematous, Rheumatoid arthritis, Temperature regulation disorder, Thrombocytopenia, Upper respiratory tract infection, |
||||
ABATACEPT, ABACAVIR SULFATE, TOCILIZUMAB, ALBUTEROL SULFATE, ALBUTEROL, ALPRAZOLAM, BUPROPION HYDROCHLORIDE, BUPROPION, BUPROPION HYDROBROMIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CITALOPRAM, CITALOPRAM HYDROBROMIDE, CLONIDINE, CLONIDINE HYDROCHLORIDE, CLONIDINE, PROGESTERONE, CYCLOBENZAPRINE, CYCLOBENZAPRINE HYDROCHLORIDE, CYCLOBENZAPRINE, MEPERIDINE HYDROCHLORIDE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DIPHENHYDRAMINE HYDROCHLORIDE, DIPHENHYDRAMINE HYDROCHLORIDE CAPSULE, LIQUID FILLED, DOLUTEGRAVIR SODIUM, ETANERCEPT, FLUTICASONE PROPIONATE, FLUCONAZOLE, FLUTICASONE PROPIONATE, FUROSEMIDE, GABAPENTIN, ADALIMUMAB, INFLIXIMAB, HYDROMORPHONE HYDROCHLORIDE, KETOPROFEN, LAMIVUDINE, LAMIVUDINE ORAL, METHYLPREDNISOLONE ACETATE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MONTELUKAST SODIUM, MONTELUKAST, MORPHINE SULFATE, MOXIFLOXACIN HYDROCHLORIDE, NORTRIPTYLINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PROGESTERONE, PROGESTERONE, PSYLLIUM HUSK, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, RITUXIMAB, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, MONTELUKAST SODIUM, MELATONIN, TEMAZEPAM, BUPROPION HYDROCHLORIDE, |
||||
| 600 | 25060090 |
US |
47 | 2 |
Erythema, Pruritus, Eye pruritus, Dermatitis atopic, Drug effect less than expected, |
||||
DUPILUMAB, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28